iLoF is a digital health company pioneering a breakthrough AI-platform to accelerate the future of personalized drug discovery and development.
Through advanced AI and Photonics, iLoF is collecting massive amounts of data to build a digital library of biomarkers and biological profiles, bringing together world-class physicists, biologists, and data scientists to get life-saving personalized treatments to patients faster.
Recognized by CB Insights as one of the top Digital Health companies
Our technology detects label-free nanosized biomarkers in biological liquid samples, to generate specific patient or disease signatures. By generating a highly focused, non-destructive laser beam guided by an optical fiber that interrogates the biological sample to obtain a digital signal of its backscattered light pattern. That signal goes through an AI pipeline to create a unique fingerprint, when compared to our database, allows us to detect modifications providing a flexible & agnostic tool that is not limited to a single use or disease.
Views and opinions expressed are however those of the author(s) only and do not necessarily reflect those of the European Union or European Innovation Council and SMEs Executive Agency (EISMEA). Neither the European Union nor the granting authority can be held responsible for them.
"*" indicates required fields
